SAN DIEGO, Nov. 13, 2018 – HealthLytix, a precision health company and developer of quantitative medical imaging solutions that leverage machine learning announces the signing of a new Platform Partner Agreement with Blackford. This agreement gives Blackford the right to promote, market, sell, distribute, and license CT CoPilot™ directly via integration with the Blackford Platform™.
CT CoPilot seamlessly integrates into existing workflow to improve radiologist efficiency, measurement accuracy, and clinical confidence by automatically generating consistent views of head CT exams. It also provides automated quantitative measurements and subtraction series to increase conspicuity of change between exams.
“We are excited to partner with Blackford and be part of their platform offering and all the benefits it offers healthcare providers. It should significantly enhance our market access and visibility while enabling radiologists to more quickly realize the efficiency and clinical confidence benefits of CT CoPilot,” says Ajit Shankaranarayanan, COO at HealthLytix.
Blackford CEO, Ben Panter said of the alliance: “”We look forward to working with HealthLytix to provide our customers and channel partners quick access to CT CoPilot through our single platform, to help provide additional clinical value for their patients.”
CT CoPilot will be launched at the upcoming Radiological Society of North America (RSNA) 2018 annual meeting in Chicago. HealthLytix personnel will be available to discuss the benefits and capabilities of CT CoPilot in the CorTechs Labs Booth #7944 – North Hall at RSNA.
To learn more about Blackford Platform applications including CT CoPilot, book a demo at RSNA or visit Blackford at Booth #7364.
At HealthLytix, we create data analytics solutions to provide comprehensive insights into health status based on genetics, quantitative imaging, and other medical information. Our products provide consumers with the benefits of early detection and targeted care, while empowering physicians with more accurate clinical decision-making across medical imaging modalities. As a precision health company, we apply proprietary machine learning algorithms to create individualized wellness assessments. We enable physicians and health systems to understand patient data, personalize treatment solutions and leverage data-driven insights into care pathway management. Learn more at www.healthlytix.com.
Blackford provide a single platform to quickly access and manage a curated marketplace of regulatory approved medical image analysis applications and AI algorithms that add clinical value. Easily integrated into existing workflows, the platform provides actionable information that allows healthcare providers to use imaging information smartly and reduce the cost of care, while improving diagnostic confidence and patient outcomes. Founded in 2010, and with operations in the United Kingdom and the United States, Blackford Analysis is backed by TRI Cap, Old College Capital, and Archangel Investors, one of the UK’s leading business angel syndicates. For more information, visit www.blackfordanalysis.com